Chimerix Inc (CMRX)
0.9658
-0.05
(-5.31%)
USD |
NASDAQ |
May 10, 16:00
0.9658
0.00 (0.00%)
After-Hours: 20:00
Chimerix Price to Book Value: 0.4972 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 0.5251 |
May 08, 2024 | 0.4997 |
May 07, 2024 | 0.5097 |
May 06, 2024 | 0.5148 |
May 03, 2024 | 0.4906 |
May 02, 2024 | 0.4892 |
May 01, 2024 | 0.4891 |
April 30, 2024 | 0.4839 |
April 29, 2024 | 0.4811 |
April 26, 2024 | 0.4633 |
April 25, 2024 | 0.4587 |
April 24, 2024 | 0.4664 |
April 23, 2024 | 0.4764 |
April 22, 2024 | 0.4705 |
April 19, 2024 | 0.4553 |
April 18, 2024 | 0.48 |
April 17, 2024 | 0.4654 |
April 16, 2024 | 0.4737 |
April 15, 2024 | 0.4708 |
April 12, 2024 | 0.4946 |
April 11, 2024 | 0.5097 |
April 10, 2024 | 0.5143 |
April 09, 2024 | 0.5097 |
April 08, 2024 | 0.5148 |
April 05, 2024 | 0.5303 |
Date | Value |
---|---|
April 04, 2024 | 0.5354 |
April 03, 2024 | 0.5354 |
April 02, 2024 | 0.52 |
April 01, 2024 | 0.5406 |
March 28, 2024 | 0.4899 |
March 27, 2024 | 0.4668 |
March 26, 2024 | 0.4575 |
March 25, 2024 | 0.455 |
March 22, 2024 | 0.4621 |
March 21, 2024 | 0.4418 |
March 20, 2024 | 0.4575 |
March 19, 2024 | 0.4437 |
March 18, 2024 | 0.5084 |
March 15, 2024 | 0.5315 |
March 14, 2024 | 0.5269 |
March 13, 2024 | 0.5407 |
March 12, 2024 | 0.5454 |
March 11, 2024 | 0.5731 |
March 08, 2024 | 0.5823 |
March 07, 2024 | 0.5823 |
March 06, 2024 | 0.5777 |
March 05, 2024 | 0.5592 |
March 04, 2024 | 0.5454 |
March 01, 2024 | 0.5407 |
February 29, 2024 | 0.5315 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3727
Minimum
Aug 18 2023
13.04
Maximum
Feb 17 2021
2.936
Average
1.305
Median
Jan 06 2020
Price to Book Value Benchmarks
UFP Technologies Inc | 6.786 |
Dentsply Sirona Inc | 1.777 |
Arbutus Biopharma Corp | 4.749 |
Pacira BioSciences Inc | 1.532 |
Karyopharm Therapeutics Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 264.83 |
Price | 0.9658 |
Earnings Yield | -97.33% |
Market Cap | 86.56M |